跳至主要内容
临床试验/NCT02951351
NCT02951351已完成不适用

Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2016年10月12日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
36
试验地点
1
主要终点
Number of Study Participants With Positive Conjunctival Culture

研究概览

简要总结

The specific aims of this study are to compare patient experience with and without a proparacaine drop after povidone iodine.

详细描述

To ensure the extra drop does not interfere with antisepsis, conjunctival cultures will be obtained from patients undergoing intravitreal injection before and after the application of the extra eye drop. Patients will be randomized to undergo additional topical analgesia during intravitreal injection vs. the standard amount of topical analgesia. Cultures of the eyelid/conjunctiva will be taken to ensure that the additional topical analgesia does not interfere with antisepsis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients undergoing intravitreal injection who do not have active eye infections
  • greater than 18 years of age

排除标准

  • patients younger than 18 years of age
  • patients with active eye infections

研究组 & 干预措施

Standard procedure + Culture

Active Comparator

Patients will undergo the standard injection protocol. A conjunctival culture will then be obtained followed by the application of povidone-iodine to the eyelashes and eyelid margins. Patients will be randomized to receive 5% povidone-iodine drop to the conjunctival surface followed by conjunctival culture then re-application of 5% povidone-iodine drop to the conjunctival surface. Injection will then proceed.

干预措施: Conjunctival culture (Procedure)

Proparacaine + Culture

Experimental

Patients will undergo the standard injection protocol. A conjunctival culture will then be obtained followed by the application of povidone-iodine to the eyelashes and eyelid margins. Patients will undergo application of another drop of topical anesthetic followed by conjunctival culture. After the culture, this group of patients will have 5% povidone iodine applied to the conjunctival surface. Intravitreal injection will then proceed.

干预措施: Proparacaine (Drug)

Proparacaine + Culture

Experimental

Patients will undergo the standard injection protocol. A conjunctival culture will then be obtained followed by the application of povidone-iodine to the eyelashes and eyelid margins. Patients will undergo application of another drop of topical anesthetic followed by conjunctival culture. After the culture, this group of patients will have 5% povidone iodine applied to the conjunctival surface. Intravitreal injection will then proceed.

干预措施: Conjunctival culture (Procedure)

结局指标

主要结局

Number of Study Participants With Positive Conjunctival Culture

时间窗: pre-injection

Conjunctival samples were collected after participants received either an additional drop of proparacaine or povidone iodine. Bacterial cultures were performed from conjunctival samples by the Mayo Clinic Microbiology laboratory. Bacterial species identification was performed on any and all bacteria that grew.

Pain at the Time of Injection

时间窗: post-injection

Subjects were asked to complete a survey about their experience with intravitreal injections after the procedure was completed. The survey was scored on a 0 to 10 numeric rating scale (NRS) where 0 was a positive response and 10 was a negative response. The lower the score, the lesser the perceived pain, the higher the score, the higher the perceived pain.

次要结局

  • Residual Pain From Intravitreal Injection(post-injection)
  • Overall Impression of Visit for Intravitreal Injection(post-injection)
  • Impression of Pre-injection Preparations(post-injection)
  • Comfort With Intravitreal Injection Standard Procedure(post-injection)
  • Expectation Intravitreal Injection Will Have Negative Consequences on Subject Health(post-injection)
  • Expectation the Injection Will Contribute to Curing/Improving Eye Condition(post-injection)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验